Reputation management

Creating or maintaining trust in the company or industry is sometimes very challenging.

Trilations supports its customers to measure and improve their company image and corporate communications. This image will be measured across the stakeholder population and compared to industry benchmarks.

Using fact-based insights and superior analytics, Trilations goes further than positioning your corporate reputation among your main competitors – we also identify what defines your reputation in order to develop actionable strategies with your cross-functional team to improve it.

 

Reputation management
Physician and patient segmentation

Physician and patient segmentation

Our aim is to assist our customers in defining a number of actionable segments or customer groups within their market. Actionability is key, given our observation that too many segmentation exercises remain unused. We differentiate ourselves in two ways.

First: the advanced and fact-based techniques we use to cut the customer universe into a number of distinct, recognizable and actionable customer segments is unique and highly effective. Second: the customer segments and their priority, together with the messaging & communication strategy by segment, are co-created with the responsible cross-functional team via a proven approach, ensuring endorsement and implementation.

Field force allocation and optimisation

The field force is by far one of the most effective (but also one of the most expensive) go-to-market instruments. Correct use of the field force provides huge leverage to the success of the company/business unit.

To allocate and optimise the field force (which can include both commercial and medical) Trilations developed a set of tools (as part of a broader approach) to simulate/optimise the field force allocation within or cross therapeutical areas within a company, taking multiple customer groups into account.

Additionally, an assessment of the field force can be performed to identify improvement areas for the group or the individual. This assessment can be regarding targeting, alignment with company goals and brand values, customer interaction performance, etc.

Field force allocation and optimisation
Trilations has a mentality that is truly inclusive and collaborative: we never get “impossible” as an answer and recommendations are always good.
Director, Investigator Engagement Strategy, in the Clinical Insights & Experience team Global R&D
Trilations always proactively comes to the table to try and sort things out. Not a lot of companies do that. Trilations really understands what we’re trying to do and they’re a true partner.
Global Business Insights Director EMEA
Trilations? In one word: smooth. Good timing, fast pick-up of questions, a flexible attitude and an outstending level of output.
Business Insights Manager EMEA
The success of the collaboration between the Global Commercial Insights Team and Trilations is the willingness to invest in each other. We have a partnership model that walks a learning journey together to find out what the best way is to deploy strategies.
Vice-President Global R&D
I appreciate the flexibility of Trilations and the time they take to apply and explain the methodology to make sure that correct insights are generated and we can draw the right conclusions.
Director, Investigator Engagement Strategy, in the Clinical Insights & Experience team Global R&D
Working with Trilations brings a tremendous competitive advantage to the table. Working with the Trilations team during the workshops, disclosing all the embedded knowledge that the Trilations teams has obtained through the years helps to drive decisions. Working with the Trilations team is very comfortable and they bring a real competitive advantage.
VP and Commercial Excellence Leader LATAM
When it comes to investment, you’re not always in the position to say “I can invest more and better than my competitor everywhere”, so you have to pick what your priorities should be and where your investments make more sense. When it comes to that granularity, Trilations’ recommendations are absolutely a critical component.
Medical Affairs Director EMEA
The Trilations team is awesome: they are flexible to work with logistically but they have also been truly strategic partners on working with us on the brands. The way they gathered and presented the customer data allowed us to make better decisions on how to move forward.
Director, Business Insights & Commercial Development LATAM
Trilations always proactively comes to the table to try and sort things out. Not a lot of companies do that. Trilations really understands what we’re trying to do and they’re a true partner.
Global Business Insights Director EMEA
What makes the work of Trilations extremely interesting to us, is that for the first time ever, different components of our company, which before had been separated, were integrated from the perspective of the customer.
Medical Affairs Director EMEA
Trilations has been working with us for a long time that they really understand our needs. They really know how to present data, how to focus on the important things. They know the market and understand the differences between different markets.
Business Insights Head EMEA
“We are committed to serving the North American and LATAM markets from our new US office. Our unique expertise in fact-based HCP insights, applied in various frameworks across the entire pharma and medical device life cycle, help your brand and company succeed!”
Bradley Tritle General Manager Americas
Questions about our expertise? Struggling with a specific challenge? I am at your service to help you find / talk about the best solution.
Hendrik Verplancke Sales Director
Our dedicated team of market strategy experts combines in-depth industry knowledge, advanced analytic & team mobilization skills to deliver high added value in all your analytical and strategic projects.
Joeri De Haes Director Japan & Asia Pacific
Our aim is to be the preferred business partner of our customers, by providing innovative, added value services via engaged consultants.
Johan Vermeiren CEO

Related Article

Private: Pharma-Customer-Centricity-Index

Read more